Pegylated L-Asparaginase

Patent No. EP2451486 (titled "Pegylated L-Asparaginase") was filed by Alize Pharma II on Jul 6, 2010. The application was issued on Jan 18, 2023.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
MATHYS & SQUIREFeb 2, 2018TITMUS

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2451486

ALIZE PHARMA II
Application Number
EP10730170A
Filing Date
Jul 6, 2010
Status
Patent Maintained As Amended
Dec 16, 2022
Publication Date
Jan 18, 2023